Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRein Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q3 2025 | 2 | -$0.26 | -$0.22 | -$0.24 |
| Q4 2025 | 2 | -$0.23 | -$0.19 | -$0.22 |
Rein Therapeutics Inc. Earnings Date And Information
Rein Therapeutics Inc. last posted its earnings results on Friday, November 14th, 2025. The company reported $-0.21 earnings per share for the quarter, topping analysts' consensus estimates of $-0.24 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Rein Therapeutics Inc. has generated $-4 earnings per share over the last year ($-3.51 diluted earnings per share) and currently has a price-to-earnings ratio of -0.62. Rein Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 6th, 2026 based on prior year's report dates.
Rein Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q3 2025 | -$0.24 | -$0.21 | 0.03 | $0 | $0 |
| 08/14/2025 | Q2 2025 | -$0.22 | -$0.28 | -0.06 | $0 | $0 |
| 03/31/2025 | Q1 2025 | N/A | -$2,510.05 | N/A | $0 | $0 |
| 04/07/2025 | Q4 2024 | -$0.14 | -$1.89 | -1.75 | $0 | $0 |
| 11/14/2024 | Q3 2024 | -$0.25 | -$0.27 | -0.02 | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.45 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | -$0.14 | -$0.86 | -0.72 | N/A | $0 |
| 12/31/2023 | Q4 2023 | -$0.16 | -$1.54 | -1.38 | N/A | $0 |
| 09/30/2023 | Q3 2023 | -$0.20 | -$0.40 | -0.2 | N/A | $0 |
| 06/30/2023 | Q2 2023 | -$0.40 | -$0.39 | 0.01 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rein Therapeutics Inc. Earnings: FAQ's
Rein Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 6th, 2026 based offlast year's report dates.
In the previous quarter, Rein Therapeutics Inc. (:RNTX) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.24 by $0.03.
The conference call for Rein Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Rein Therapeutics Inc.'s latest earnings report can be read online.
Rein Therapeutics Inc. (:RNTX) has a recorded net income of $-62,883,000.Rein Therapeutics Inc. has generated $-3.51 earnings per share over the last four quarters.
Rein Therapeutics Inc. (:RNTX) has a price-to-earnings ratio of -0.62 and price/earnings-to-growth ratio is -260.57.